- Home
- CNM vs RVMD Comparison
CNM vs RVMD Comparison
Compare CNM & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNM
- RVMD
- Stock Information
- Founded
- CNM 1996
- RVMD 2014
- Country
- CNM United States
- RVMD United States
- Employees
- CNM N/A
- RVMD N/A
- Industry
- CNM Durable Goods
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CNM Consumer Discretionary
- RVMD Health Care
- Exchange
- CNM Nasdaq
- RVMD Nasdaq
- Market Cap
- CNM 9.7B
- RVMD 8.7B
- IPO Year
- CNM 2021
- RVMD 2020
- Fundamental
- Price
- CNM $56.81
- RVMD $40.16
- Analyst Decision
- CNM Buy
- RVMD Strong Buy
- Analyst Count
- CNM 10
- RVMD 13
- Target Price
- CNM $56.50
- RVMD $65.15
- AVG Volume (30 Days)
- CNM 1.9M
- RVMD 1.3M
- Earning Date
- CNM 12-03-2024
- RVMD 02-24-2025
- Dividend Yield
- CNM N/A
- RVMD N/A
- EPS Growth
- CNM 0.85
- RVMD N/A
- EPS
- CNM 2.11
- RVMD N/A
- Revenue
- CNM $7,183,000,000.00
- RVMD $742,000.00
- Revenue This Year
- CNM $12.40
- RVMD N/A
- Revenue Next Year
- CNM $4.25
- RVMD $1,855.56
- P/E Ratio
- CNM $26.83
- RVMD N/A
- Revenue Growth
- CNM 8.24
- RVMD N/A
- 52 Week Low
- CNM $37.22
- RVMD $26.56
- 52 Week High
- CNM $62.15
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- CNM 73.24
- RVMD 31.31
- Support Level
- CNM $50.00
- RVMD $39.48
- Resistance Level
- CNM $55.93
- RVMD $42.97
- Average True Range (ATR)
- CNM 1.41
- RVMD 1.48
- MACD
- CNM 0.41
- RVMD -0.07
- Stochastic Oscillator
- CNM 98.23
- RVMD 13.59
About CNM Core & Main Inc.
Core & Main Inc is a specialty distributor focusing on water, wastewater, storm drainage, and fire protection products and services. Catering to municipalities, private water companies, and contractors, it serves municipal, non-residential, and residential markets nationwide. Its diverse product line includes pipes, valves, fittings, storm drainage products, fire protection products, and meter products. Revenue is primarily generated from pipes, valves, and fittings. The company operates across three construction sectors: municipal, non-residential, and residential, contributing to reliable infrastructure development nationwide.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.